 "Sun Pharma")
Shares of Sun Pharmaceutical Industries hit an over five-month low of Rs 475 per share, slipping 7%, and falling 9% from its early morning high on Tuesday on the back of heavy volumes. The stock was trading at its lowest level since June 6, 2018, declining 11% in past three days.
Sun Pharma was up 2% to Rs 521 in intra-day trade after the drug maker said that it has settled Modafinil antitrust litigation with certain US plaintiffs.
“Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in the In re
Sun Pharma was up 2% to Rs 521 in intra-day trade after the drug maker said that it has settled Modafinil antitrust litigation with certain US plaintiffs.
“Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in the In re
